Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia
Leukemia, Published online: 26 February 2024; doi:10.1038/s41375-024-02162-5Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia
Source: Leukemia - Category: Hematology Authors: Ruth de Tute Nicholas Counsell Laura Clifton-Hadley Shirley D ’Sa Guy Pratt Gavin Campbell Lauren Campbell Ross Sadler William Townsend Bilyana Popova Paul Smith Oliver Schofield Roger Owen Rebecca Auer Source Type: research
More News: Hematology | Leukemia | Macroglobulinemia | Rituxan | Velcade | Waldenstrom's Macroglobulinemia